Company: BIAF
Filing Date: 2025-05-27
Form Type: 424B5
Source: 0001641172-25-012410
Chunk: 19

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 424B5
Chunk 19
---
 with respect to us and the securities we are offering under this prospectus supplement, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement. Neither we nor the Sales Agent has authorized any person to provide you with different information. We are not making an offer of these shares of common stock in any state where the offer is not permitted. You should not assume that the information in this prospectus supplement is accurate as of any date other than the date on the front page of this prospectus supplement, regardless of the time of delivery of this prospectus supplement or any sale of the securities offered by this prospectus supplement.

We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public at the SEC’s website at www.sec.gov. Our SEC filings are also available on our website, www.bioaffinitytech.comunder the heading “Investor Relations—SEC Filings.” The reference to our website is an inactive textual reference only, the information contained in, and that can be accessed through our website, is not incorporated into and is not a part of this prospectus supplement. We make available on our website our SEC filings as soon as reasonably practicable after those reports are filed with the SEC.

| S-9 |

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate by reference” information into this prospectus supplement, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be part of this prospectus supplement and the accompanying base prospectus, and information in documents that we subsequently file with the SEC will automatically update and supersede information in this prospectus supplement and the accompanying base prospectus. The SEC file number for the documents incorporated by reference in this prospectus supplement and the accompanying base prospectus is 001-41463. The documents incorporated by reference into this prospectus supplement and the accompanying base prospectus contain important information that you should read about us.

The following documents are incorporated by reference into this prospectus supplement:

| ● 
 ● | Our                                                                                                                                    
 Annual Report on Form 10-K and Annual Report on Form 10-K/A for the fiscal year ended December 31, 2024 filed with the SEC on March    
 31, 2025 and April 29, 2025, respectively;                                                                                             
 Our                                                                                                                                    
 Quarterly Report